These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11120209)
1. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation. Chien NC; Lin FL; Chou NK; Hsu RB; Wang SS; Chu SH; Ko WJ Transplant Proc; 2000 Nov; 32(7):2380-2. PubMed ID: 11120209 [No Abstract] [Full Text] [Related]
2. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center. Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565 [No Abstract] [Full Text] [Related]
3. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum. Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669 [No Abstract] [Full Text] [Related]
4. Effect of mycophenolate mofetil in heart transplantation. Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414 [TBL] [Abstract][Full Text] [Related]
5. Influence of rejection on late graft function after heart transplantation. Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855 [No Abstract] [Full Text] [Related]
7. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. Marcus N; Khaghani A; Burke M; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460 [No Abstract] [Full Text] [Related]
8. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. Cantarovich M; de Gruchy S; Forbes C; Marpole D; Elstein E; Magnan C; de Varennes B Transplant Proc; 1999; 31(1-2):79. PubMed ID: 10083015 [No Abstract] [Full Text] [Related]
12. Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute. Beaufigeau M; Dumesnil D; Carrier M; White M; Pelletier GB Transplant Proc; 1997 Nov; 29(7A):10S-12S. PubMed ID: 9366918 [No Abstract] [Full Text] [Related]
13. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3. Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282 [TBL] [Abstract][Full Text] [Related]
14. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation. Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332 [No Abstract] [Full Text] [Related]
15. Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction. Cantarovich M; Quantz M; Elstein E; Ergina P; Magnan C; de Varennes B Transplant Proc; 2000 Mar; 32(2):446-8. PubMed ID: 10715475 [No Abstract] [Full Text] [Related]
16. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
17. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. GrinyĆ³ JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567 [TBL] [Abstract][Full Text] [Related]
18. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
19. Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation. Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A Transplant Proc; 1998 Aug; 30(5):1912-4. PubMed ID: 9723330 [No Abstract] [Full Text] [Related]
20. Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation. Taylor DO; Kfoury AG; Pisani B; Hammond EH; Renlund DG Transplant Proc; 1997 Dec; 29(8A):13S-15S. PubMed ID: 9414668 [No Abstract] [Full Text] [Related] [Next] [New Search]